Timber Pharmaceuticals

$1.90
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.23 (-10.85%) Today
+$0.01 (+0.53%) As of 8:03 AM UTC after-hours

Why Robinhood?

You can buy or sell TMBR and other stocks, options, and ETFs commission-free!

About TMBR

Timber Pharmaceuticals, Inc. operates as a biopharmaceutical company, which focuses on the development and commercialization of treatments for orphan dermatologic diseases. Its initial focus on developing non-systemic treatments for rare dermatologic diseases, including congenital ichthyosis, tuberous sclerosis complex and localized scleroderma.

CEO
John Koconis
Employees
3
Headquarters
Basking Ridge, New Jersey
Founded
2019
Market Cap
65.69M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
2.80M
High Today
$2.17
Low Today
$1.86
Open Price
$2.17
Volume
2.37M
52 Week High
$10.44
52 Week Low
$0.6651

TMBR Earnings

-$1.36
-$0.79
-$0.22
$0.35
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Apr 5, Pre-Market

You May Also Like

KRG
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure